364 Zero Itch in Eyes Treated With Olopatadine Hydrochloride Ophthalmic Solution, 0.2% in Bilateral Conjunctival Allergen Challenge Studies

Documenti analoghi

• Efficacy and safety of olopatadine hydrochloride 0.77% in patients with allergic conjunctivitis using a conjunctival allergen-challenge model
  di: Torkildsen, Gail, et al.
  Pubblicazione: (2015)
• Comparative efficacy of bepotastine besilate 1.5% ophthalmic solution versus olopatadine hydrochloride 0.2% ophthalmic solution evaluated by patient preference
  di: McCabe, Craig F, et al.
  Pubblicazione: (2012)
• A multicenter evaluation of the efficacy and duration of action of alcaftadine 0.25% and olopatadine 0.2% in the conjunctival allergen challenge model
  di: Ackerman, Stacey, et al.
  Pubblicazione: (2013)
• Maintenance of remission with low-dose olopatadine hydrochloride for itch in well-controlled chronic urticaria
  di: Makino, Teruhiko, et al.
  Pubblicazione: (2012)
• 2 Dose Optimizing Study of a Depigmented Polymerized Allergen Extract of Birch Pollen by Means of Conjunctival Provocation Test
  di: Sager, Angelika, et al.
  Pubblicazione: (2012)